SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Focused Visit (Follow-up) — Katharine Hepburn

PatientKatharine Hepburn
Date of birth1953-05-12
IdentifiersMRN HR-ML012-SYN; SSN (made up) 000-12-8834
Document date2026-05-05
AuthorGwendolyn Price, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Three-month tremor review after starting propranolol and voice therapy. [S]

History of Present Illness

Ms. Hepburn returns three months after her first visit and twelve weeks after starting propranolol extended-release 60 mg each morning. Her hands are steadier: she can carry a full cup again and signs letters more easily, though writing still tires her hand. The head tremor is about the same. She finished the six-week voice therapy course a month ago and uses breath support and a slightly higher pitch on stage, which steadies sustained notes. She has had no lightheadedness on standing, wheeze, cold hands, unusual tiredness, vivid dreams, or low mood, and no falls. Occupational therapy has not yet been booked. [S]

ElementDetail
MedicinePropranolol extended-release 60 mg daily for twelve weeks; no side effects
TremorHands steadier; head tremor unchanged
Voice therapySix-week course completed; strategies in use
FallsNone

Review of Systems

SystemResultFinding
NeurologicalPositiveHand tremor better; head tremor unchanged; no stiffness or imbalance
RespiratoryNegativeNo wheeze or breathlessness
CardiovascularNegativeNo lightheadedness, fainting, or cold hands
PsychiatricNegativeMood good; sleeping well; PHQ-9 score 3

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Propranolol extended-release 60 mg oral capsule, one capsule by mouth once dailyOne capsule by mouth each morningOral route2026-02-10activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-05-05Body height170cmS
2026-05-05Body weight56.4kgS
2026-05-05Body mass index (BMI) [Ratio]19.5kg/m2S
2026-05-05Systolic blood pressure122mm[Hg]S
2026-05-05Diastolic blood pressure72mm[Hg]S
2026-05-05Heart rate64/minS
2026-05-05Respiratory rate14/minS
2026-05-05Body temperature36.6CelS
2026-05-05Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-05-05Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S

Physical Exam

Vital signs recorded on 2026-05-05; see the Vital Signs section. [S]

SystemFinding
GeneralAlert and energetic
CardiovascularRegular rhythm at 64 per minute; seated blood pressure 122/72 mmHg
RespiratoryClear; no wheeze
NeurologicalTETRAS performance subscale 16, down from 22; daily-living subscale 9, down from 14. Smaller postural and kinetic hand tremor; head tremor unchanged; steadier sustained vowel. No rest tremor, bradykinesia, or rigidity

Problems

ProblemClinical statusVerificationCodeProvenance
Essential tremor: bilateral upper-limb action tremor with head (no-no) and voice tremor, without other neurological signsactiveprovisional G25.0S — Synthetic modern coding of her publicly visible tremor; the label is a retrospective interpretation (R), so verification is provisional. Severity scores are synthetic.
Voice tremor due to essential tremor, mild, with a wavering pitch on sustained vowelsactiveconfirmed R49.8S — Synthetic modern coding anchored to public descriptions of her quivery voice; the severity at the index age is synthetic.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationTremor rating: TETRAS performance and activities of daily living subscalesEvery visitCompleted todayPerformance subscale 16, down from 22; daily-living subscale 9, down from 14
ExaminationArchimedes spiral drawing and handwriting sampleEvery visitCompleted todaySmaller tremor waves in both spirals; handwriting steadier
ExaminationExamination for signs beyond tremor (rest tremor, bradykinesia, rigidity, dystonia, ataxia, cognitive change)At diagnosis, then yearly or with a change in the tremorUp to dateNo new signs; full review by neurology three months ago
ExaminationResting heart rate and seated and 3-minute standing blood pressureEvery visit on a beta-blockerDeferredPulse 64 and seated blood pressure 122/72 mmHg were recorded, but the 3-minute standing blood pressure was not measured, a deviation from the every-visit item after starting a beta-blocker. She has no lightheadedness or falls, and the standing pressure at the six-month review showed no orthostatic drop, so no harm resulted. Corrective action: standing blood pressure is added to the rooming checklist for every visit on propranolol
Medication safetyBeta-blocker safety: wheeze, slow pulse or heart block, fatigue, cold hands, low mood, hypoglycemia awarenessEvery visitCompleted todayNo wheeze, fatigue, cold hands, or vivid dreams; pulse 64
Medication safetyPrimidone safety: sedation, unsteadiness, nauseaEvery visit on primidoneNot indicatedNot on primidone; propranolol is working
Medication safetyDrugs and substances that worsen tremor (beta-agonists, valproate, lithium, antidepressants, excess thyroid hormone, caffeine)Every visitCompleted todayNo new medicines; coffee unchanged
ExaminationFall query, with Timed Up and Go yearlyEvery visitCompleted todayNo falls
SurveyMood (PHQ-9)Before a beta-blocker, after starting it, then yearlyCompleted todayPHQ-9 3 after twelve weeks on propranolol; no depression
LaboratoryTSH and basic chemistry to exclude metabolic causesOnce at diagnosis; again only with a change in the tremorUp to dateNormal at diagnosis; no change in the tremor to repeat them
ReferralSpeech-language therapy for voice tremorWhen voice tremor affects speech or workCompleted todaySix-week course of 12 sessions completed a month ago
ReferralOccupational therapy for adaptive aidsWhen tremor limits daily tasksDueNot yet booked; to be arranged now
Medication safetyBotulinum toxin for head or voice tremorIf head or voice tremor is disablingNot indicatedHead tremor does not trouble her; voice steadier
ReferralReferral for focused ultrasound thalamotomy or deep brain stimulationIf disabling limb tremor persists after adequate trials of propranolol and primidoneNot indicatedGood response to the first medicine
SurveyCognitive screen (MoCA)YearlyUp to dateMoCA 28 four months ago
Medication safetyAGS Beers Criteria medication reviewYearly from age 65Up to dateReviewed three months ago; no new medicines
Self-managementAdvance care planning and goals of careAt least yearly from 65DueAt the annual wellness visit in the autumn
Self-managementVaccination status (influenza, pneumococcal, zoster, COVID-19, Tdap)Yearly, per the CDC scheduleDueAt the annual wellness visit

Goal progress:

Guideline basis: Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology (2011); Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology (2005); Consensus Statement on the classification of tremors, from the task force on tremor of the International Parkinson and Movement Disorder Society (2018); MDS evidence-based review of treatments for essential tremor (2019); CMID: Clinical Monitoring Intelligence Database, general items for older adults (no essential tremor monograph) (2026)

Follow-up: Six-month tremor review in three months, with seated and standing blood pressure. Occupational therapy to be booked. Next scheduled visit 2026-08-04: six-month tremor review. [S]